AL
GCVRZ

Arnhold LLC’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Arnhold LLC’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18,900
Closed -$11K – 136
2019
Q3 		$11K Sell
18,900
-44,917
-70% -$24.2K ﹤0.01% 131
2019
Q2 		$33K Hold
63,817
– – 0.01% 131
2019
Q1 		$29K Hold
63,817
– – 0.01% 128
2018
Q4 		$31K Hold
63,817
– – 0.01% 134
2018
Q3 		$36K Sell
63,817
-82,585
-56% -$44.3K 0.01% 135
2018
Q2 		$73K Hold
146,402
– – 0.01% 142
2018
Q1 		$62K Buy
+146,402
New +$58.9K 0.01% 139

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Arnhold LLC's GCVRZ Position: Q4 2019 in Review

Arnhold LLC sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2019, closing a stake of 18,900 shares — an estimated $11K sold.

Arnhold LLC first reported a position in GCVRZ in Q1 2018 and held it in 7 quarters. The position peaked at $73K in Q2 2018. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2019.

  • Arnhold LLC reported no remaining Sanofi Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Arnhold LLC sold 18,900 Sanofi Contingent Value Rights shares in Q4 2019, an estimated $11K.
  • Arnhold LLC first reported a position in Sanofi Contingent Value Rights in Q1 2018 and held it in 7 quarters.
  • Arnhold LLC's Sanofi Contingent Value Rights position peaked at $73K in Q2 2018.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2019.

Based on Arnhold LLC's 13F filing for Q4 2019, filed 5 Feb 2020.